Park Hyung Jun, Choi Young-Chul, Oh Ji Won, Yi Sang-Wook
Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Neuroepidemiology. 2020;54(4):313-319. doi: 10.1159/000505815. Epub 2020 Jan 29.
Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous disorders that primarily affect the peripheral nervous system. Epidemiological studies of CMT have not yet been performed in Korea.
This study was performed to estimate the prevalence of CMT in Korea and the socioeconomic status, mortality, and causes of death of Korean patients with CMT.
Data on patients with CMT were obtained from the rare intractable disease registry and the National Health Insurance Service for the years 2005-2018.
During the study period, 2,885 CMT patients were enrolled. The prevalence per 100,000 persons in 2018 was 5.2 (6.1 for men and 4.4 for women), peaking at ages 15-39 years, with almost twice as many men (n = 714) as women (n = 402) in this age group. Of the CMT patients, 226 (7.8%) were receiving medical aid, a public assistance program targeting poor individuals, at the time of diagnosis and 253 (8.8%) at last follow-up or death. From 2005 to 2017, 170 patients died, including 118 men and 52 women. The standardized mortality ratio (SMR) was 1.57 (95% CI 1.34-1.83) for all patients and did not differ in men and women. Age-specific SMR was highest in patients aged under 9 years, gradually declining thereafter. Neurologic disease as a cause of death was significantly more frequent in CMT patients than in the general population.
This was the first nationwide epidemiologic study of CMT patients in Korea. This study confirmed the characteristics associated with the prevalence of and mortality from CMT by age and is the first to report the socioeconomic status and causes of death of CMT patients.
夏科-马里-图斯病(CMT)是一组临床和遗传异质性疾病,主要影响周围神经系统。韩国尚未开展CMT的流行病学研究。
本研究旨在估计韩国CMT的患病率以及韩国CMT患者的社会经济状况、死亡率和死亡原因。
2005年至2018年期间,从罕见难治性疾病登记处和国民健康保险服务处获取CMT患者的数据。
在研究期间,共纳入2885例CMT患者。2018年每10万人中的患病率为5.2(男性为6.1,女性为4.4),在15-39岁达到峰值,该年龄组男性(n = 714)人数几乎是女性(n = 402)的两倍。在CMT患者中,226例(7.8%)在诊断时接受医疗救助(一项针对贫困人口的公共援助计划),253例(8.8%)在最后一次随访或死亡时接受医疗救助。2005年至2017年,170例患者死亡,其中男性118例,女性52例。所有患者的标准化死亡率(SMR)为1.57(95%CI 1.34-1.83),男性和女性之间无差异。年龄特异性SMR在9岁以下患者中最高,此后逐渐下降。CMT患者中因神经系统疾病导致的死亡明显高于普通人群。
这是韩国首次针对CMT患者开展的全国性流行病学研究。本研究证实了CMT患病率和死亡率随年龄的相关特征,并且首次报告了CMT患者的社会经济状况和死亡原因。